Related Experiment Video
Updated: Aug 28, 2025
23:33
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
83.8K
Stroke Prevention in Atrial Fibrillation.
1Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Current Cardiology Reports
|September 22, 2022
Summary
Atrial fibrillation (AF) stroke prevention is advancing with novel anticoagulants and left atrial appendage closure. Digital health tools are improving AF detection, but optimal risk stratification for device-detected AF requires further study.
Area of Science:
- Cardiology
- Neurology
- Digital Health
Background:
- Atrial fibrillation (AF) significantly increases stroke and systemic embolism risk.
- Effective stroke prevention is crucial for managing AF patients.
Purpose of the Study:
- To review current strategies for stroke prevention in atrial fibrillation.
- To discuss recent advances in antithrombotic therapies and digital health for AF detection.
Main Methods:
- Literature review of recent studies on AF stroke prevention.
- Analysis of novel oral anticoagulants (NOACs), left atrial appendage (LAA) closure, and digital health devices.
Main Results:
- NOACs have largely replaced warfarin for AF stroke prevention.
- LAA closure is a viable alternative for patients who cannot use anticoagulation.
- Consumer-directed AF screening via digital devices is increasing.
Conclusions:
- Stroke prevention remains a priority in AF management.
- Further research is needed to determine the stroke risk associated with device-detected AF and the benefit of anticoagulation for short/infrequent episodes.
- Digital health plays a growing role in AF detection and guiding stroke prevention strategies.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
18
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
18
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
858
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
858
01:26Coronary Artery Disease IV: Preventive Measures
31
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31
01:25Dysrhythmias VI: Management of Dysrhythmias
104
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
104
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
01:29Disturbances in Heart Rhythm
1.2K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
1.2K